1. Home
  2. MFA vs AURA Comparison

MFA vs AURA Comparison

Compare MFA & AURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MFA Financial Inc.

MFA

MFA Financial Inc.

HOLD

Current Price

$8.60

Market Cap

957.0M

Sector

Real Estate

ML Signal

HOLD

Logo Aura Biosciences Inc.

AURA

Aura Biosciences Inc.

HOLD

Current Price

$6.37

Market Cap

797.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MFA
AURA
Founded
1997
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
957.0M
797.5M
IPO Year
1998
2021

Fundamental Metrics

Financial Performance
Metric
MFA
AURA
Price
$8.60
$6.37
Analyst Decision
Buy
Strong Buy
Analyst Count
6
5
Target Price
$11.05
$20.00
AVG Volume (30 Days)
1.4M
628.3K
Earning Date
05-05-2026
05-08-2026
Dividend Yield
14.16%
N/A
EPS Growth
58.54
N/A
EPS
0.23
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$10.02
N/A
P/E Ratio
$36.74
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.36
$4.73
52 Week High
$10.43
$9.54

Technical Indicators

Market Signals
Indicator
MFA
AURA
Relative Strength Index (RSI) 41.28 29.62
Support Level N/A $6.10
Resistance Level $8.99 $6.69
Average True Range (ATR) 0.15 0.32
MACD -0.01 -0.11
Stochastic Oscillator 30.91 8.10

Price Performance

Historical Comparison
MFA
AURA

About MFA MFA Financial Inc.

MFA Financial Inc is a specialty finance company that invests in and finances residential mortgage assets. Its principal business objective is to deliver shareholder value through the generation of distributable income and through asset performance linked to residential mortgage credit fundamentals. The company selectively invests in residential mortgage assets with a focus on credit analysis, projected prepayment rates, interest rate sensitivity and expected return. The company's reportable segments include mortgage-related assets; and Lima One.

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

Share on Social Networks: